These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13765381)

  • 21. Hypertensive angina treated with cyclospasmol; report on a case.
    BARRETT CT
    S Afr Med J; 1952 Sep; 26(36):734. PubMed ID: 13005025
    [No Abstract]   [Full Text] [Related]  

  • 22. A new treatment for nocturnal leg cramps.
    PERCHUK E; WEINREB M; AKSU A
    Angiology; 1961 Mar; 12():102-4. PubMed ID: 13734220
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasodilator drugs for peripheral vascular disease.
    GOODWIN JF
    Br Med J; 1960 Jun; 1(5188):1800-3. PubMed ID: 13851099
    [No Abstract]   [Full Text] [Related]  

  • 24. The melting-point of cyclospasmol and the quantitative determination of small amounts of 3.5.5.-trimethylcyclohexyl phenylglyoxylate in same.
    REKKER RF; ERNSTING MJ; NAUTA WT
    Pharm Weekbl; 1956 Jan; 91(1):1-6. PubMed ID: 13310216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of peripheral vascular diseases with a new vasodilator agent].
    MARINONI E; ZUCCHI C
    Minerva Cardioangiol; 1960 Dec; 8():597-607. PubMed ID: 13766848
    [No Abstract]   [Full Text] [Related]  

  • 26. Investigation into 3.5.5-trimethylcyclohexyl mandelate (cyclospasmol).
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 Feb; 91(3):81-90. PubMed ID: 13310218
    [No Abstract]   [Full Text] [Related]  

  • 27. CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES.
    SMITH AL
    Angiology; 1965 Jan; 16():1-7. PubMed ID: 14258038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dilatropon in the treatment of peripheral vascular diseases].
    FABI M
    Arcisp S Anna Ferrara; 1959; 12():75-84. PubMed ID: 13821185
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of a new vasodilator agent in management of peripheral arterial insufficiency.
    SAMUELS SS; SHAFTEL HE
    J Am Med Assoc; 1959 Sep; 171():142-5. PubMed ID: 14441294
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution to the clinical study of a new vasodilator].
    BENINI P; COSSU G
    Minerva Chir; 1960 Apr; 15():429-44. PubMed ID: 13798881
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic activity of cyclospasmol (3,5,5-trimethylcyclohexanol mandelic ester) in coronary & peripheral vascular diseases; casuistic contribution].
    BALLERINI C; FIORE G
    Gazz Med Ital; 1959 Apr; 118(4):136-41. PubMed ID: 13664047
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral vasodilation: methods of evaluation and the correlation with clinical practice.
    KAINDI F
    Angiology; 1960 Feb; 11():15-20. PubMed ID: 14404025
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of nylidrin hydrochloride on the skin and muscle temperature of patients with occlusive arterial disease of the lower extremities.
    ROEDLING HA; ROTH GM; SCHIRGER A; GIFFORD RW
    Angiology; 1960 Apr; 11():130-2. PubMed ID: 14438272
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and treatment of peripheral vascular diseases; experience with cyclospasmol].
    NIEVEEN J; RODBARD JA; VAN WIJK TW
    Ned Tijdschr Geneeskd; 1954 Jan; 98(4):205-16. PubMed ID: 13144906
    [No Abstract]   [Full Text] [Related]  

  • 37. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers].
    DUGOIS P; COLOMB L; GAGNAIRE J
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502
    [No Abstract]   [Full Text] [Related]  

  • 38. [Actein, a fluid extract from Actaea racemosa, in the medical therapy of peripheral arteriopathies].
    STARACE G; NOFERI A; SALDAMARCO G
    Clin Ter; 1962 May; 22():823-9. PubMed ID: 13916295
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydergine, a vasodilator; clinical report on hydergine in peripheral vascular disease.
    STICK WD
    Pa Med J; 1956 Sep; 59(9):1072-4. PubMed ID: 13359090
    [No Abstract]   [Full Text] [Related]  

  • 40. Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    HAMILTON RR
    Practitioner; 1960 Mar; 184():367-9. PubMed ID: 14399278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.